Artelus
AI‑powered eye disease screening for early detection and intervention
Ready to see Artelus in action?
Book a personalized demo with our team.
Overview
Artelus empowers healthcare by leveraging deep learning algorithms to analyze retinal images for early detection of diseases such as diabetic retinopathy, glaucoma, ARMD, and more. Its products include AI‑integrated fundus and OCT analysis systems that generate high‑accuracy reports and heatmaps, supporting clinical decisions. The platform is designed for use by clinics, NGOs, and healthcare professionals, focusing on accessibility, explainability, and real‑world performance. Artelus also contributes research and innovation in expanding diagnostics to additional disease areas.
Who It's For
Ophthalmologists, Clinics & Hospitals, NGOs & Public Health Organizations, Healthcare Providers
Key Strengths
AI‑powered diagnosticsEarly disease detectionPortable imaging integrationExplainable results
Primary Use Cases
Early diabetic retinopathy screening
Retinal disease risk detection (e.g., glaucoma, ARMD)
Point‑of‑care diagnostic imaging
AI‑assisted clinical decision support
Technical Specifications
Supported AI Models
Proprietary deep learning
Deployment Methods
CloudOn-premise
Supported Languages
English
Security & Compliance
CE‑class
Company Information
Location
Bengaluru, India
Company Size
11-50 employees